# OnCo record ingo-mellinghoff (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/ingo-mellinghoff/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "ingo-mellinghoff" ;
  schema:name "Ingo K. Mellinghoff"@en ;
  schema:description "Led INDIGO, the trial that made vorasidenib the first targeted therapy for low-grade IDH-mutant glioma."@en ;
  schema:url <https://onco.cc/people/ingo-mellinghoff/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Mellinghoff%20IK%5BAuthor%5D%20glioma%20vorasidenib> ;
  onco:tag "glioma", "idh", "targeted-therapy" ;
  schema:jobTitle "Chair, Department of Neurology, Memorial Sloan Kettering Cancer Center" ;
  schema:sameAs <https://orcid.org/0000-0002-4347-8149> ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:targets <https://onco.cc/targets/idh/> ;
  onco:drugs <https://onco.cc/drugs/vorasidenib/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  onco:trials <https://onco.cc/trials/indigo/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-indigo-nejm-2023/> ;
  schema:affiliation <https://onco.cc/institutions/mskcc/> .